To determine the causes of blindness and low vision in patients consulting a tertiary ophthalmologic center in northern Thailand.
V
isual impairment is one of the most common disabilities: an estimated 45 million people worldwide are blind, and 200 million people have low vision. [1] [2] [3] Population-based studies have shown that the main causes of blindness worldwide (in addition to refraction abnormalities) are age-related cataract and glaucoma. 1, 3 The prevalence of blindness and low vision due to infectious diseases, including human immunodeficiency virus (HIV)-related visual impairment, is not known. Cytomegalovirus (CMV) retinitis has not yet been recognized as an important cause of blindness, despite the huge burden of HIV infection in various areas of the world such as Southeast Asia and Africa. In Thailand during the last decades, ophthalmologic care has been aimed at the major causes of blindness (cataract and glaucoma surgery along with prevention of nutritional diseases), and the prevalence of bilateral blindness has decreased dramatically from 1.1% to 0.31%. 4, 5 Nothing is known about the causes of blindness and low vision in patients consulting the tertiary centers in Southeast Asia, nor have the most frequent disorders and needs of patients consulting these centers been identified. In this study, we investigated the causes of blindness and low vision in a large university teaching hospital serving the whole of northern Thailand and paid specific attention to intraocular infections, specifically CMV retinitis.
Methods
Of 2,951 new consecutive patients consulting the Department of Ophthalmology at University Hospital in Chiang Mai, Thailand, from February 1 to June 31, 2005, 369 (12.5%) with bilateral or unilateral blindness and/or low vision were prospectively selected for the study.
The World Health Organization's definitions of blindness (corresponding to corrected visual acuity of Ͻ0.05 or 20/400) and low vision (corresponding to corrected visual acuity of Յ0.30 or 20/60) were used in this study. 6, 7 Patients were assessed according to anatomical location and etiology of the main cause of blindness. In addition, preventability and curability of blindness were also registered. These data were analyzed for both patients (n ϭ 369) and affected eyes (n ϭ 519). When a combination of diverse causes leading to blindness and/or low vision was noted, the most direct cause of visual loss was selected. If this selection was not possible, the cases were classified separately as combinations (n ϭ 12). The refraction abnormalities were not represented among the causes of visual loss, except where there was still subnormal vision with optimal correction (e.g., amblyopia).
Anatomical location of the cause of blindness in glaucoma was classified as optic disk blindness. The etiology of primary open-angle glaucoma was classified as unknown, as was that of rhegmatogenous retinal detachment (with the exception of myopic and traumatic cases). Reversible blindness and low vision were considered in patients with cataract (possibility of surgery). The preventable category included trauma and glaucoma (except congenital glaucoma) as well as CMV retinitis in HIV-infected patients (possibility of highly active antiretroviral therapy [HAART] ). In intraocular inflammations, treatable loss of vision was considered in identified infectious causes, whereas the treatability of visual loss in uveitis of unknown cause was considered unknown. Blindness due to retinal vascular occlusions, age-related macular degeneration, and optic atrophy was considered not preventable and not reversible.
Data for patients were computerized and statistically analyzed by means of the 2 test and Fisher exact test. P Ͻ 0.05 was considered statistically significant.
Results
Our study included 369 patients with blindness or low vision, of whom 150 (41%) had bilateral loss and 219 (59%) had unilateral loss (519 affected eyes) ( Table 1 ). The male-to-female ratio was 1:1, and the mean age of the patients was 52 years (median, 54 years; range, 4 -87 years).
The main causes of visual impairment and blindness are listed in Table 2 . The most common etiological causes were age-related ocular diseases (128 patients [35%], of whom 123 had cataract and the remainder had other age-related ocular disorders), followed by infections (66 patients [18%]) and trauma (43 patients [12%]). After age-related causes, infections were the second major cause of both blindness and low vision (21% and 14%, respectively). Although trauma was predominantly encountered in blindness (P ϭ 0.006), age-related disorders were more frequently noted in low vision (P Ͻ 0.001).
The classification of patients according to severity and laterality of visual loss is listed in Table 3 . For all 369 patients, the main anatomical location of visual loss was the lens with cataract (134 [36%]/369, in- cluding age-related cataract and cataract from other causes such as traumatic, juvenile, or others), which was followed by disorders of the retina and/or uvea (126 [35%]/369). Active CMV retinitis was the cause of visual loss in 11% (42) of 369 patients, while age-related macular degeneration was the cause only in 0.8% (3) Patients with blindness and low vision were further subdivided according to four separate categories (bilateral blindness, unilateral blindness, bilateral low vision, and unilateral low vision; Table 4 ). Retinal and/or uveal disorders were a major cause of blindness (76 [38%]/202 patients), whereas cataract was the main cause of low vision (76 [46%]/167 patients). The association of unilateral blindness with trauma and a marginally higher prevalence of bilateral blindness with CMV retinitis were also observed. When 150 patients with bilateral visual loss were subdivided into blindness (n ϭ 73) and low vision (n ϭ 77) groups and compared, no differences emerged in terms of location or etiological cause of visual loss (all locations and causes, P ϭ 0.1). When the data were evaluated for affected eyes (n ϭ 519), a higher percentage of blindness and low vision due to bilateral diseases was noted (e.g., cataract). No other differences were observed. Blindness and low vision were considered preventable (n ϭ 126) and/or reversible (n ϭ 134) in 260 (70%) of 369 cases. Of 73 patients with bilateral blindness, 30 (42%) had cataract and 26 (36%) had retinal/uveal disorders, of whom 14 (19%) had active CMV retinitis.
Discussion
The leading causes of blindness and low vision at a large tertiary center in northern Thailand were agerelated diseases and ocular infections, which were predominantly cases of CMV retinitis in HIV-infected patients. Bilateral active CMV retinitis was present in 19% of all patients with bilateral blindness. Loss of vision was considered preventable and/or reversible in most patients.
The very high percentage of CMV retinitis among blind patients at a tertiary center is striking. Immuno- *Included patients with bilateral retinal detachment due to CMV retinitis (n ϭ 2), diabetic retinopathy (n ϭ 3), myopia (n ϭ 1), trauma (n ϭ 1), and non-human immunodeficiency virus uveitis (n ϭ 1) and 10 patients with idiopathic bilateral retinal detachment.
†In the group with myopic amblyopia, some patients with a combination of amblyopia and myopic retinal changes might have been included. The exact distinction between pure myopic amblyopia and myopic retinal degenerations and combinations was not feasible in this study.
CMV, cytomegalovirus; AMD, age-related macular degeneration; NA, not applicable.
suppression due to acquired immunodeficiency syndrome is a serious public health problem in Southeast Asia. Recent data indicate that the prevalence of HIV infection among the whole population of Thailand is 1.5%. 8, 9 Before the era of HAART, Ϸ30% of patients with acquired immunodeficiency syndrome in industrialized countries developed CMV retinitis. 10, 11 The combination of HAART and effective anti-CMV drugs has improved the visual prognosis for patients with CMV retinitis and has dramatically reduced the risk of developing bilateral blinding disease in the industrialized world. The rates of vision loss among eyes with CMV retinitis observed in the era of HAART are approximately eightfold less than the rates reported in pre-HAART studies. 12, 13 In Thailand, the prevalence of CMV retinitis was reported to be 21% (42/200 patients) in a cross-sectional study in 1996 14 and 33% in a prospective study of newly diagnosed HIV-positive patients in 2003. 15 Therefore, 33% of HIV-infected persons in Thailand can expect to develop CMV retinitis at some point during the course of their illness. Thailand's national program for access to antiretroviral treatment began in 2002, in which cheaper generic antiretroviral drugs are locally produced and distributed in all government hospitals through the Universal Coverage Project. Unfortunately, so far, not all HIV-positive patients receive HAART. 16 It is expected that locally produced HAART will be increasingly used and that the life expectancy of HIV-infected persons will increase. Hopefully, after implementation of HAART for HIVinfected persons, CMV as a cause of blindness (with yet undefined magnitude in Southeast Asia) will decrease. However, some investigators have warned that the initial increase of CMV-induced blindness (related to a longer life for those who already have CMV retinitis) might be tremendous. 17 Our study illustrates that the causes of blindness encountered in a tertiary center differ from those reported for the whole population, which is not surprising. Our study did not attempt to replace an epidemiologic survey on blindness but aimed to analyze the specific disorders that the tertiary ophthalmologic centers are confronted with and, consequently, to determine which specific demands these centers should anticipate. We attempted to reveal the answers to questions entirely different from those of epidemiologic studies. The pattern of diseases encountered in a tertiary center undoubtedly reflects the local diagnostic and therapeutic possibilities; in addition, the referral patterns might also be influenced by age, availability of the center, and socioeconomic position of the patients. The patients attending tertiary centers are in part (self-selected) from a local area and referred from a much larger area. Although the basic medical coverage in Thailand also includes the elderly and the very poor, it is possible that these groups of patients might be underrepresented. The referral bias in the number of patients with acquired immunodeficiency syndrome and CMV retinitis is very high because tertiary centers are the only centers for treatment of CMV retinitis. In our population, the roles of glaucoma and age-related macular degeneration in blindness and low vision were negligible. The recent availability of therapeutic and surgical options for glaucoma might also have influenced the low number of cases of glaucoma-induced blindness in this university hospital. Future population studies will allow further analyses of visual impairment and blindness according to age and further distinctions, topics out of the scope of the present study.
The expertise of treating CMV retinitis in Southeast Asia is localized in tertiary centers. Our results indicate that precise data on the prevalence and incidence 
